Home BIO Issues Statement on Hepatitis C medicines report.
 

Keywords :   


BIO Issues Statement on Hepatitis C medicines report.

2015-12-07 14:31:08| Industrial Newsroom - All News for Today

In his statement regarding report released by Senators Grassley and Wyden, BIO Senior VP of Communications Kenneth Lisaius stated that BIO is reviewing said report in full and generally does not comment on product pricing by member companies. Lisaius added, however, that "balanced debate about the cost of groundbreaking cures" cannot narrow their focus on price but also acknowledge value provided to patients as well as overall healthcare system.

Tags: report issues statement bio

Category:Industrial Goods and Services

Latest from this category

All news

19.11POWTEX2024 The 25th International Powder Technology Exhibition Tokyo
Industrial Goods and Services »
23.11 #249
23.11muta5
23.1120
23.11BabolaT VS BUG4300 24ss
23.11
23.11 TYO26cm
23.112
23.11CW-X 2.0
More »